Truveta is a Washington-based SaaS platform that offers solutions such as EHR data and analytics for the healthcare industry.
$320M
Jan 12, 2025
-
Vyriad is a Minnesota-based biotechnology company that develops and commercializes oncolytic virus therapies for the treatment of cancer.
$29.5M
May 16, 2022
-
ISA is a Netherlands-based biopharmaceutical company that develops and commercializes cellular immunotherapies for the treatment of cancer and SARS diseases.
$30.8M
Jul 11, 2021
-
DNAnexus is a California-based cloud platform that offers solutions such as genomic analysis, compliance and clinical trials for the healthcare sector.
$100M
Jun 08, 2020
-
Vyriad is a Minnesota-based biotechnology company that develops and commercializes oncolytic virus therapies for the treatment of cancer.
$24.4M
Oct 29, 2019
-
Frequently Asked Questions about Regeneron
What is Regeneron investing in?
Regeneron has invested in 6 companies including Truveta, Vyriad and ISA
What company did Regeneron invest in?
Regeneron invested in a total 6 companies including Truveta, Vyriad and ISA
What are the top 5 investments by Regeneron?
The top companies in which Regeneron invested are Truveta, Vyriad, ISA, DNAnexus and Vyriad
